Company Overview and News

0
Bourse caps four-day rally amid lack of leads

17h bworldonline
The bellwether Philippine Stock Exchange index (PSEI) snapped its four-day winning streak Monday, July 16, dropping 29.74 points or 0.4% to end at 7,369.44, while the broader all-shares index gave up 12.29 points or 0.27% to finish at 4,462.60.
SVTMF PSKXF BDOUY AYAAY SM BDOUF BDO SMIVY MWP PHSXY PSE MWIDE ALI AYAAF

0
PSEi ends four-day rally

21h bworldonline
Local equities slumped on Monday, July 16, as the market continued to consolidate within range due to lack of catalysts.
SVTMF PSKXF BDOUY AYAAY SM BDOUF BDO SMIVY MWP PHSXY PSE MWIDE ALI AYAAF

0
Rise; Indonesia, Malaysia extend rally to 5th session

2018-07-13 theedgemarkets
(July 13): Southeast Asian stock markets edged higher on Friday, with Indonesia and Malaysia extending gains to a fifth consecutive session, as worries over U.S.-China trade tensions eased.
SMPH SMIVY SVTMF SPHXY SM SPHXF SPHZF

0
PSEi bucks regional downturn, posts 1.39% gain

2018-07-11 business.inquirer.net
The local stock barometer climbed back to the 7,300 level yesterday, bucking the downturn across regional markets albeit in thin trading volume.
SMIVY PSKXF SVTMF AYAAY PHSXY SM PSE ALI AYAAF

0
PSEi jumps as investors pick up large-cap issues

2018-07-11 bworldonline
THE MAIN INDEX jumped on Wednesday on selective buying of large-cap firms, as most investors remained on the sidelines due to lack of new leads.
SUMMITSEC 533306 SMIVY PSKXF SVTMF AYAAY PHSXY SM PSE ALI AYAAF

0
Most fall as China-U.S. trade spat ramps up

2018-07-11 theedgemarkets
(July 11): Southeast Asian stock markets fell on Wednesday, with Singapore erasing some of the last two sessions' gains and Vietnam extending losses to a third session, as Washington warned of tariffs on an additional US$200 billion worth of Chinese imports, escalating the trade dispute.
SMIVY SVTMF SM PETFF

0
PSEi closes up 0.65%

2018-07-10 business.inquirer.net
The benchmark Philippine Stock Exchange Index (PSEi) closed above the 7,200 level yesterday, lifted by bargain hunters.
ICT SVTMF BDOUY AYAAY JBFCY SM AEV ICTEF BDOUF BDO SMIVY JBFCF ABTZY JFC ALI AYAAF

0
PSEi ends 4-day rebound on inflation news

2018-07-05 business.inquirer.net
The local stock barometer returned to the doldrums yesterday as investors were unnerved by news about the country’s higher-than-expected June inflation rate against the backdrop of mostly sluggish regional markets.
SMIVY PSKXF SVTMF AYAAY PHSXY SM PSE ALI AYAAF

0
Philippines sheds over 1%; others wary before U.S. tariff deadline

2018-07-05 theedgemarkets
(July 5): Philippine shares fell more than 1% on Thursday, after the country's June inflation hit an over five-year high, while other markets in the region were subdued on caution ahead of Friday's deadline for further U.S. tariffs on Chinese goods.
SMIVY U14 SVTMF UOLGF SGAPY SM UOLGY COL SNGNF

0
PSEi rallies to 7,300 level, but market still seen technically weak

2018-07-04 business.inquirer.net
The local stock barometer rallied to the 7,300 level yesterday on the back of some foreign inflows amid expectations that the market may have found the bottom.
BDOUF BDO SMIVY PSKXF SVTMF BDOUY SYBJF PHSXY SM PSE SECB

0
Stocks rally on bargain hunting ahead of data

2018-07-04 bworldonline
LOCAL STOCKS jumped to their fourth straight day of gains on Wednesday as investors continued to search for bargains given the main index’s historically low valuation.
SMPH SMIVY PSKXF SVTMF SPHXY PHSXY SM PSE SPHXF SPHZF

0
Stocks rally as investors hunt for bargains

2018-07-04 bworldonline
Local stocks climbed on Wednesday as investors continued to search for bargains given the main index’s historically low valuation.
SMPH SMIVY PSKXF SVTMF SPHXY PHSXY SM PSE SPHXF SPHZF

0
Most fall as fears of more U.S. tariffs keep investors on edge

2018-07-04 theedgemarkets
(July 4): Most Southeast Asian stock markets fell on Wednesday, tracking Asian peers on caution ahead of the Friday deadline for further U.S. tariffs on China, with Philippine shares snapping a three-session gaining streak on profit-taking.
SMIVY JBFCF SVTMF JFC JBFCY SM

1
South-east Asia stocks mostly down on fears of more US tariffs

2018-07-04 malaymail
SINGAPORE, July 4 — Most South-east Asian stock markets fell today tracking Asian peers on caution ahead of the Friday deadline for further US tariffs on China, with Philippine shares snapping a three-session gaining streak on profit-taking.
SMIVY JBFCF SVTMF JFC JBFCY SM

0
Shares climb in thin trade ahead of inflation data

2018-07-03 bworldonline
SHARES firmed up on Tuesday amid thin trading as investors stayed on the sidelines ahead of the release of June inflation data.
SMIVY PSKXF SVTMF URC AYAAY PHSXY SM PSE UVRBY ALI UVRBF AYAAF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

49m - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

22h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 78455R205